These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16091284)

  • 1. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.
    Kondapi AK; Padmaja G; Satyanarayana N; Mukhopadyaya R; Reitz MS
    Arch Biochem Biophys; 2005 Sep; 441(1):41-55. PubMed ID: 16091284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
    Kondapi AK; Satyanarayana N; Saikrishna AD
    Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
    Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
    Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
    Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
    Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways.
    Mandraju RK; Kondapi AK
    Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
    Sai Krishna AD; Panda G; Kondapi AK
    Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
    Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY; Beck WT
    Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis.
    Null AP; Hudson J; Gorbsky GJ
    Cell Growth Differ; 2002 Jul; 13(7):325-33. PubMed ID: 12133901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
    Liang H; Wu X; Yalowich JC; Hasinoff BB
    Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association and DNA binding properties of the human topoisomerase IIA alpha2HTH module.
    Morant-Lhomel A; René B; Zargarian L; Troalen F; Mauffret O; Fermandjian S
    Biochimie; 2006; 88(3-4):253-63. PubMed ID: 16213649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
    Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
    Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
    Boege F
    Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
    Sakaguchi A; Kikuchi A
    J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic DNA topoisomerase II beta.
    Austin CA; Marsh KL
    Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase II.
    Sorensen TK; Grauslund M; Jensen PB; Sehested M; Jensen LH
    Biochem Biophys Res Commun; 2005 Sep; 334(3):853-60. PubMed ID: 16053917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorella virus Marburg topoisomerase II: high DNA cleavage activity as a characteristic of Chlorella virus type II enzymes.
    Dickey JS; Choi TJ; Van Etten JL; Osheroff N
    Biochemistry; 2005 Mar; 44(10):3899-908. PubMed ID: 15751965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles of Topoisomerase II isoforms: DNA damage accelerating alpha, double strand break repair promoting beta.
    Mandraju RK; Kannapiran P; Kondapi AK
    Arch Biochem Biophys; 2008 Feb; 470(1):27-34. PubMed ID: 18021738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
    Jensen LH; Thougaard AV; Grauslund M; Søkilde B; Carstensen EV; Dvinge HK; Scudiero DA; Jensen PB; Shoemaker RH; Sehested M
    Cancer Res; 2005 Aug; 65(16):7470-7. PubMed ID: 16103101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.